Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lane T, Fontana M, Martinez-Naharro A, Quarta CC, Whelan CJ, Petrie A, Rowczenio DM, Gilbertson JA, Hutt DF, Rezk T, et al. Natural history, quality of life, and outcome in cardiac transthyretin amyloidosis. Circulation. 2019;140:16–26. https://doi.org/10.1161/CIRCULATIONAHA.118.038169.
Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, Nair AP, Nativi-Nicolau J, Ruberg FL, American Heart Association Heart Failure and Transplantation Committee of the Council on Clinical Cardiology. Cardiac amyloidosis: evolving diagnosis and management: a scientific statement from the American Heart Association. Circulation. 2020;142(1):e7–22.
Jain A, Zahra F. Transthyretin amyloid cardiomyopathy (ATTR-CM). In: StatPearls [Internet]. StatPearls Publishing; 2021.
Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, Pozniakoff T, Ruberg FL, Miller EJ, Berk JL, et al. Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis. JAMA Cardiol. 2016;1:880–9. https://doi.org/10.1001/jamacardio.2016.2839.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Buxton, D., Gibbs, H. (2023). Heart Failure with Preserved Ejection Fraction: You Don’t Know What You Don’t Look for. In: Junckerstorff, R., Brady, S., Aung, A.K. (eds) Beyond Evidence-Based Medicine. Springer, Singapore. https://doi.org/10.1007/978-981-99-4440-8_35
Download citation
DOI: https://doi.org/10.1007/978-981-99-4440-8_35
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-4439-2
Online ISBN: 978-981-99-4440-8
eBook Packages: MedicineMedicine (R0)